Flomics Biotech is a Catalan company that has developed a diagnostic method based on analysis of nucleic acids present in the blood. Through a liquid biopsy, they detect the early phase of complex illnesses such as colorectal cancer, where an early diagnosis doubles the possibilities of survival.
Biotechnology, Genetics, Health Care
Between €500K-€ 1 million
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Flomics? We’re happy to assist you with our Startup Sourcing service.